Academic Rank

 PGY 4 Neurology Resident

Other Information

Why did you pick WSU/DMC Neurology residency:

There are several unique characteristics of the WSU/DMC residency program which makes it very desirable for me and I believe for everyone who is looking for a comprehensive experience for their residency training in Neurology. The patient population is very unique while diverse, which provides the trainees with a spectacularly wide range of ailments at  different stages of the disease which might not be accessible in most other training programs. Also, due to the extent of work and relatively large spectrum of expectations from the house officers, the autonomy can be limitless while it is handled with responsibility. Overall, I find WSU/DMC a friendly environment with boundless opportunities for learning and I am excited to proudly have my degree from this program shine on my CV very soon.
 

Medical

Oregon Health and Science University, Portland, Oregon

Internships

DMC - Sinai Grace Hospital, Detroit, MI, USA

Interests

I love Detroit and this is definitely not something I was prepared for before moving to Michigan. It has been changing for the better every day and being part of this transformation has been an amazing and unique experience which I could have never planned for this perfectly. Detroit has been revitalized and it is amazing.

Research interest: Pain, Neuro-Oncology, Epilepsy, Stroke, Neuro-Imaging, movement disorders and deep brain stimulation.

Publications

1. Nasseri, M., Gahramanov, S., Netto, J.P., Fu, R., Muldoon, L.L., Varallyay, C., Hamilton, B.E., Neuwelt, E.A., Epub 2014 Feb 11. Evaluation of pseudoprogression in patients with glioblastoma multiforme using dynamic magnetic resonance imaging with ferumoxytol calls RANO criteria into question. Neuro Oncol. 16(8):1146-54 PMID 24523362

2. Raslan, A.M., Nasseri, M., Bahgat, D., Abdu, E., Burchiel, K.J., Epub 2011 Feb 2. Motor cortex stimulation for trigeminal neuropathic or deafferentation pain: an institutional case series experience. Stereotact Funct Neurosurg. 2011; 89, 83-8. PMID 21293167

3. Cetas, J.S., Nasseri, M., Saedi, T., Kuang, A.A., Selden, N.R., Epub 2013 Apr 12. Delayed intracranial hypertension after cranial vault remodeling for nonsyndromic single-suture synostosis. J Neurosurg Pediatr. Jun 2013; 11, 661-6. PMID 23581636

4. Farrell, B.T., Hamilton, B.E., Dosa, E., Rimely, E., Nasseri, M., Gahramanov, S., Lacy, C.A., Frenkel, E.P., Doolittle, N.D., Jacobs, P.M., Neuwelt, E.A., Epub 2013 Jun 14. Using iron oxide nanoparticles to diagnose CNS inflammatory diseases and PCNSL. Neurology. Jul 2013. 81, 256-63. PMID 23771486

5. Neuwelt, A.J., Nguyen, T.M., Fu, R., Bubalo, J., Tyson, R.M., Lacy, C.A., Gahramanov, S., Nasseri, M., Neuwelt, E.A, Barnes, P.D., Jul 2014. Incidence of Pneumocystis jirovecii pneumonia after temozolomide for CNS malignancies without prophylaxis. CNS Oncology 2014 Jul;3(4):267-73 PMD 25286038

6. Gahramanov S., Varallyay C, Tyson, R.M., Lacy, C., Nasseri, M., Netto JP, White, T., Gultekin, S.H., Woltjer, R.L., Neuwelt, E.A., Diagnosis of pseudoprogression using MRI perfusion in patients with glioblastoma may predict improved survival. CNS Oncology 2014 Nov; 3(6):389-400 [PubMed - in process]

7. Gahramanov, S., Tyson, R.M., Lacy, C., Fu, R, Prola Netto, J., Nasseri, M., White, T., woltjer, R.L., Gultekin, S.H., Neuwelt, E.A., In Revision. Extension of adjuvant temozolomide may improve survival in patients with newly diagnosed glioblastoma while presence of pseudorprogression can predict better outcome. J. Clin Oncology
 

← Return to listing